SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-13-000085
Filing Date
2013-05-14
Accepted
2013-05-14 16:44:18
Documents
4
Period of Report
2013-05-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 NLNK 20130514 8K nlnk20130514-8xk.htm 8-K 62041
2 CERTIFICATE OF AMENDMENT TO RESTATED CERTIFICATE OF INCORPORATION nlnk20130514-8xkxex31.htm EX-3.1 9779
3 NON-EMPLOYEE DIRECTORS' STOCK AWARD PLAN nlnk20130514-8xkxex101.htm EX-10.1 141733
4 EMPLOYEE STOCK PURCHASE PLAN nlnk20130514-8xkxex102.htm EX-10.2 77036
  Complete submission text file 0001126234-13-000085.txt   291951
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 13842186
SIC: 2834 Pharmaceutical Preparations